Unknown

Dataset Information

0

Elevated Lactate Dehydrogenase (LDH) level as an independent risk factor for the severity and mortality of COVID-19.


ABSTRACT: Early identification of severe patients with coronavirus disease 2019 (COVID-19) is very important for individual treatment. We included 203 patients with COVID-19 by propensity score matching in this retrospective, case-control study. The effects of serum lactate dehydrogenase (LDH) at admission on patients with COVID-19 were evaluated. We found that serum LDH levels had a 58.7% sensitivity and 82.0% specificity, based on a best cut-off of 277.00 U/L, for predicting severe COVID-19. And a cut-off of 359.50 U/L of the serum LDH levels resulted in a 93.8% sensitivity, 88.2% specificity for predicting death of COVID-19. Additionally, logistic regression analysis and Cox proportional hazards model respectively indicated that elevated LDH level was an independent risk factor for the severity (HR: 2.73, 95% CI: 1.25-5.97; P=0.012) and mortality (HR: 40.50, 95% CI: 3.65-449.28; P=0.003) of COVID-19. Therefore, elevated LDH level at admission is an independent risk factor for the severity and mortality of COVID-19. LDH can assist in the early evaluating of COVID-19. Clinicians should pay attention to the serum LDH level at admission for patients with COVID-19.

SUBMITTER: Li C 

PROVIDER: S-EPMC7467395 | biostudies-literature | 2020 Aug

REPOSITORIES: biostudies-literature

altmetric image

Publications

Elevated Lactate Dehydrogenase (LDH) level as an independent risk factor for the severity and mortality of COVID-19.

Li Chang C   Ye Jianfang J   Chen Qijian Q   Hu Weihua W   Wang Lingling L   Fan Yameng Y   Lu Zhanjin Z   Chen Jie J   Chen Zaishu Z   Chen Shiyan S   Tong Junlu J   Xiao Wei W   Mei Jin J   Lu Hongyun H  

Aging 20200814 15


Early identification of severe patients with coronavirus disease 2019 (COVID-19) is very important for individual treatment. We included 203 patients with COVID-19 by propensity score matching in this retrospective, case-control study. The effects of serum lactate dehydrogenase (LDH) at admission on patients with COVID-19 were evaluated. We found that serum LDH levels had a 58.7% sensitivity and 82.0% specificity, based on a best cut-off of 277.00 U/L, for predicting severe COVID-19. And a cut-o  ...[more]

Similar Datasets

| S-EPMC7666711 | biostudies-literature
| S-EPMC7526632 | biostudies-literature
| S-EPMC7251362 | biostudies-literature
| S-EPMC7343511 | biostudies-literature
| S-EPMC5894102 | biostudies-literature
| S-EPMC8763698 | biostudies-literature
| S-EPMC8388961 | biostudies-literature
| S-EPMC4578581 | biostudies-literature
| S-EPMC3344892 | biostudies-literature
| S-EPMC4555275 | biostudies-literature